Minor
PreVail-PH2 · Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure · Pulmonary Hypertension Group 2 (PreVail-PH2 Study)
Primary completion pushed from Dec 2026 to Jun 2027
Also in this update: Study completion pushed from Jul 1, 2028 to Jun 1, 2030
Gradient Denervation TechnologiesNot applicable NCT06052072 Registry history of NCT06052072 on ClinicalTrials.gov (opens the registry)